Birdshot Chorioretinitis in Patients Aged 80 and Older

References

• Ryan S, Maumenee AE. Birdshot retinochoroidopathy. Am J Ophthalmol. 1980;89(1):31–45. Published 1980. doi:10.1016/0002-9394(80)90226-3.
   PubMed Web of Science ®Google Scholar
• Levinson RD, Brezin A, Rothova A, Accorinti M, Holland GN. Research criteria for the diagnosis of birdshot chorioretinopathy: results of an international consensus conference. Am J Ophthalmol. 2006;141(1):185–187. doi:10.1016/j.ajo.2005.08.025.
   PubMed Web of Science ®Google Scholar
• Classification criteria for birdshot chorioretinitis. Am J Ophthalmol. 2021;228:65–71. doi:10.1016/j.ajo.2021.03.059.
   PubMed Web of Science ®Google Scholar
• Shah KH, Levinson RD, Yu F, et al. Birdshot chorioretinopathy. Surv Ophthalmol. 2005;50(6):519–541. doi:10.1016/j.survophthal.2005.08.004.
   PubMed Web of Science ®Google Scholar
• Rothova A, TTJM B, Probst K, van Kooij B, Baarsma GS. Birdshot chorioretinopathy: long-term manifestations and visual prognosis. Ophthalmology. 2004;111(5):954–959. doi:10.1016/j.ophtha.2003.09.031.
   PubMed Web of Science ®Google Scholar
• You C, Lasave AF, Kubaisi B, et al. Long-term outcomes of systemic corticosteroid-sparing immunomodulatory therapy for birdshot retinochoroidopathy. Ocul Immunol Inflamm. 2020;28(6):966–974. doi:10.1080/09273948.2019.1641610.
   PubMed Web of Science ®Google Scholar
• Kiss S, Ahmed M, Letko E, Foster CS. Long-term follow-up of patients with birdshot retinochoroidopathy treated with corticosteroid-sparing systemic immunomodulatory therapy. Ophthalmology. 2005;112(6):1066–1071. doi:10.1016/j.ophtha.2004.12.036.
   PubMed Web of Science ®Google Scholar
• Monnet D, Brézin AP, Holland GN, et al. Longitudinal cohort study of patients with birdshot chorioretinopathy. I. Baseline clinical characteristics. Am J Ophthalmol. 2006;141(1):135–142. doi:10.1016/j.ajo.2005.08.067.
   PubMed Web of Science ®Google Scholar
• Holland GN, Shah KH, Monnet D, et al. Longitudinal cohort study of patients with birdshot chorioretinopathy II: color vision at baseline. Am J Ophthalmol. 2006;142(6):1013–1018. doi:10.1016/j.ajo.2006.06.065.
   PubMed Web of Science ®Google Scholar
• Monnet D, Levinson RD, Holland GN, Haddad L, Yu F, Brézin AP. Longitudinal cohort study of patients with birdshot chorioretinopathy. III. Macular imaging at baseline. Am J Ophthalmol. 2007;144(6):818–828. doi:10.1016/j.ajo.2007.08.011.
   PubMed Web of Science ®Google Scholar
• Gordon LK, Monnet D, Holland GN, Brézin AP, Yu F, Levinson RD. Longitudinal cohort study of patients with birdshot chorioretinopathy. IV. Visual field results at baseline. Am J Ophthalmol. 2007;144(6):829–837. doi:10.1016/j.ajo.2007.08.010.
   PubMed Web of Science ®Google Scholar
• Gordon LK, Goldhardt R, Holland GN, Yu F, Levinson RD. Standardized visual field assessment for patients with birdshot chorioretinopathy. Ocul Immunol Inflamm. 2006;14(6):325–332. doi:10.1080/09273940600966400.
   PubMed Web of Science ®Google Scholar
• Nussenblatt RB, Palestine AG, Chan CC, Roberge F. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology. 1985;92(4):467–471. doi:10.1016/s0161-6420(85)34001-0.
   PubMed Web of Science ®Google Scholar
• Imamura Y, Fujiwara T, Margolis R, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina. 2009;29(10):1469–1473. doi:10.1097/IAE.0b013e3181be0a83.
   PubMed Web of Science ®Google Scholar
• Neri P, Lettieri M, Fortuna C, Manoni M, Giovannini A. Inflammatory choroidal neovascularization. Middle East Afr J Ophthalmol. 2009;16(4):245–251. doi:10.4103/0974-9233.58422.
   PubMedGoogle Scholar
• Agarwal A, Invernizzi A, Singh RB, et al. An update on inflammatory choroidal neovascularization: epidemiology, multimodal imaging, and management. J Ophthalmic Inflamm Infect. 2018;8:13. doi:10.1186/s12348-018-0155-6.
   PubMed Web of Science ®Google Scholar
• Böni C, Thorne JE, Spaide RF, et al. Fundus autofluorescence findings in eyes with birdshot chorioretinitis. Invest Ophthalmol Vis Sci. 2017;58(10):4015–4025. doi:10.1167/iovs.17-21897.
   PubMed Web of Science ®Google Scholar
• Thorne JE, Jabs DA, Kedhar SR, Peters GB, Dunn JP. Loss of visual field among patients with birdshot chorioretinopathy. Am J Ophthalmol. 2008;145(1):23–28. doi:10.1016/j.ajo.2007.08.039.
   PubMed Web of Science ®Google Scholar
• Reddy AK, Gonzalez MA, Henry CR, Yeh S, Sobrin L, Albini TA. Diagnostic sensitivity of indocyanine green angiography for birdshot chorioretinopathy. JAMA Ophthalmol. 2015;133(7):840–843. doi:10.1001/jamaophthalmol.2015.0822.
   PubMed Web of Science ®Google Scholar
• Cao JH, Silpa-Archa S, Freitas-Neto CA, Foster CS. Birdshot chorioretinitis lesions on indocyanine green angiography as an indicator of disease activity. Retina. 2016;36(9):1751–1757. doi:10.1097/IAE.0000000000000967.
   PubMed Web of Science ®Google Scholar
• Becker MD, Wertheim MS, Smith JR, Rosenbaum JT. Long-term follow-up of patients with birdshot retinochoroidopathy treated with systemic immunosuppression. Ocul Immunol Inflamm. 2005;13(4):289–293. doi:10.1080/09273940490912407.
   PubMed Web of Science ®Google Scholar
• Thorne JE, Sugar EA, Holbrook JT, et al. Periocular triamcinolone vs. intravitreal triamcinolone vs. intravitreal dexamethasone implant for the treatment of uveitic macular edema: the PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) trial. Ophthalmology. 2019;126(2):283–295. doi:10.1016/j.ophtha.2018.08.021.
   PubMed Web of Science ®Google Scholar
• Thorne JE, Jabs DA, Peters GB, Hair D, Dunn JP, Kempen JH. Birdshot retinochoroidopathy: ocular complications and visual impairment. Am J Ophthalmol. 2005;140(1):45–51. doi:10.1016/j.ajo.2005.01.035.
   PubMed Web of Science ®Google Scholar
• Silpa-Archa S, Lee JJ, Boonsopon S, et al. Poor prognostic factors in patients with birdshot retinochoroidopathy. Retina. 2016;36(11):2220–2226. doi:10.1097/IAE.0000000000001051.
   PubMed Web of Science ®Google Scholar